Change of Control Agreements in the Pharmaceuticals Industry

235 Contracts & Agreements

Browse by Company

Aclaris Therapeutics, Inc. (1 contract)
ALDER BIOPHARMACEUTICALS INC (1)
ALIMERA SCIENCES INC (1)
Altus Pharmaceuticals Inc. (5)
Amag Pharmaceuticals (1)
AMYLIN PHARMACEUTICALS INC (3)
Anacor Pharmaceuticals, Inc. (1)
ANADYS PHARMACEUTICALS INC (7)
ANI Pharma Inc (1)
ARADIGM CORP (6)
Athira Pharma, Inc. (10)
AVANIR PHARMACEUTICALS, INC. (6)
Bristol-Myers Squibb (6)
COLLAGENEX PHARMACEUTICALS INC (2)
Corcept Therapeutics Incorporated (19)
DiCE MOLECULES HOLDINGS, LLC (1)
DURECT CORP (3)
Edgewise Therapeutics, Inc. (1)
Eloxx Pharmaceuticals, Inc. (1)
EYEGATE PHARMACEUTICALS INC (2)
GRAYBUG VISION, INC. (1)
GW PHARMACEUTICALS PLC (7)
IMARA Inc. (8)
Innoviva, Inc. (5)
INSPIRE PHARMACEUTICALS INC (5)
ISTA PHARMACEUTICALS INC (1)
Jaguar Health, Inc. (1)
Jazz Pharmaceuticals plc (6)
KOS PHARMACEUTICALS INC (1)
Lilly (Eli) & Co. (4)
Liquidia Corp (3)
Liquidia Technologies Inc (1)
Mallinckrodt (4)
MAP Pharmaceuticals, Inc. (3)
MARINUS PHARMACEUTICALS INC (1)
Merck (3)
MILLENNIUM PHARMACEUTICALS INC (1)
Molecular Insight Pharmaceuticals, Inc. (2)
MyoKardia Inc (3)
NEKTAR THERAPEUTICS (4)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (3)
ONYX PHARMACEUTICALS INC (2)
OSCIENT PHARMACEUTICALS CORP (1)
OSI PHARMACEUTICALS INC (8)
Paratek Pharmaceuticals, Inc. (19)
Perrigo (4)
Pfizer (3)
PONIARD PHARMACEUTICALS, INC. (23)
QUESTCOR PHARMACEUTICALS INC (1)
RADIENT PHARMACEUTICALS Corp (1)
Rani Therapeutics Holdings, Inc. (2)
Reliant Pharmaceuticals, Inc. (2)
Sagent Pharmaceuticals, Inc. (1)
Satsuma Pharmaceuticals, Inc. (1)
SCICLONE PHARMACEUTICALS INC (13)
Theravance Biopharma, Inc. (1)
Valera Pharmaceuticals Inc (1)
Ventyx Biosciences, Inc. (1)
Verona Pharma plc (1)
VIVUS INC (4)

Recent Contracts

Change in Control Agreement between the Registrant and Robert Renninger (Athira Pharma, Inc., Filed With SEC on September 17, 2024)
Liquidia Corporation Amended and Restated Executive Severance and Change in Control Plan (Liquidia Corp, Filed With SEC on May 14, 2024)
Anish Patel Change in Control and Severance Agreement (IMARA Inc., Filed With SEC on March 14, 2024)
Joseph Lyssikatos Change in Control and Severance Agreement (IMARA Inc., Filed With SEC on March 14, 2024)
Benjamin Hohl Change in Control and Severance Agreement (IMARA Inc., Filed With SEC on March 14, 2024)
Helen Collins Change in Control and Severance Agreement (IMARA Inc., Filed With SEC on March 14, 2024)
Sam Kintz Change in Control and Severance Agreement (IMARA Inc., Filed With SEC on March 14, 2024)
2007 Change in Control Severance Pay Plan for Select Employees, as amended (Lilly (Eli) & Co., Filed With SEC on February 21, 2024)
Amended and Restated Executive Change in Control and Severance Benefit Plan, dated as of May 3, 2023 (Jazz Pharmaceuticals plc, Filed With SEC on August 9, 2023)
Change in Control and Severance Agreement between the Company and Andrew Gengos, dated as of May 18, 2023 (Athira Pharma, Inc., Filed With SEC on May 22, 2023)
Benjamin Hohl Change in Control and Severance Agreement, dated February 23, 2023 (IMARA Inc., Filed With SEC on March 1, 2023)
Helen Collins Change in Control and Severance Agreement, dated February 23, 2023 (IMARA Inc., Filed With SEC on March 1, 2023)
Sam Kintz Change in Control and Severance Agreement, dated February 23, 2023 (IMARA Inc., Filed With SEC on March 1, 2023)
First Amendment to the Theravance Biopharma, Inc. Change in Control Severance Plan (Theravance Biopharma, Inc., Filed With SEC on November 9, 2022)
Executive Change in Control and Severance Plan (Ventyx Biosciences, Inc., Filed With SEC on May 9, 2022)
Change in Control and Severance Agreement between the Registrant and Kevin Church (Athira Pharma, Inc., Filed With SEC on March 28, 2022)
Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and William Guyer, dated February 9, 2022 (Corcept Therapeutics Incorporated, Filed With SEC on February 15, 2022)
Amended and Restated Change in Control and Severance Agreement between the Company and Mark Litton, Ph.D (Athira Pharma, Inc., Filed With SEC on January 31, 2022)
Change in Control Severance Agreement between Alimera Sciences, Inc., and Philip J. Ashman, Ph.D. as of July 16, 2021 (ALIMERA SCIENCES INC, Filed With SEC on November 5, 2021)
Form of Change in Control and Severance Agreement (DiCE MOLECULES HOLDINGS, LLC, Filed With SEC on September 9, 2021)
Change in Control and Severance Agreement between the Registrant and Mark Worthington (Athira Pharma, Inc., Filed With SEC on August 16, 2021)
Change in Control and Severance Agreement between the Registrant and Rachel Lenington (Athira Pharma, Inc., Filed With SEC on August 16, 2021)
Verona Pharma plc Employee Change in Control Severance Benefit Plan (Verona Pharma plc, Filed With SEC on August 11, 2021)
Form of Participation Agreement under the Rani Therapeutics Holdings, Inc. Severance and Change in Control Plan (Rani Therapeutics Holdings, Inc., Filed With SEC on July 9, 2021)
Rani Therapeutics Holdings, Inc. Severance and Change in Control Plan (Rani Therapeutics Holdings, Inc., Filed With SEC on July 9, 2021)
Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Atabak Mokari, dated March 1, 2021 (incorporated by reference to Exhibit 10.2 to the... (Corcept Therapeutics Incorporated, Filed With SEC on May 6, 2021)
Liquidia Corporation Executive Severance and Change in Control Plan (Liquidia Corp, Filed With SEC on March 25, 2021)
Executive Change in Control and Severance Plan (Edgewise Therapeutics, Inc., Filed With SEC on March 5, 2021)
Executive Change of Control Policy, as amended December 9, 2020 (DURECT CORP, Filed With SEC on March 5, 2021)
Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Atabak Mokari, dated March 1, 2021 (Corcept Therapeutics Incorporated, Filed With SEC on March 1, 2021)
Form of GW UK Change in Control and Severance Benefit Plan Participation Agreement (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Form of Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement for EVP Participation (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Form of Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement for Existing EVP Participation (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Change in Control and Severance Benefit Plan Participation Agreement, dated February 25, 2021, by and between GW Pharmaceuticals plc and Geoffrey Guy (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement, dated February 25, 20201, between Greenwich Biosciences,... (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
GW UK Change in Control and Severance Benefit Plan (GW Pharma Limited / GW Research Limited) (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Change in Control Severance Benefit Plan, effective January 1, 2017, as amended by First Amendment to Change in Control Severance Benefit Plan, effective October 2, 2019 (Aclaris Therapeutics, Inc., Filed With SEC on February 25, 2021)
2007 Change in Control Severance Pay Plan for Select Employees, as amended (Lilly (Eli) & Co., Filed With SEC on February 17, 2021)
Change in Control and Severance Policy (MyoKardia Inc, Filed With SEC on November 5, 2020)